sonesitatug vedotin

News

AstraZeneca has served up a robust set of interim results, leavened by strong sales of cancer drugs, but with some mixed pipeline news on the side.

News

In another blow to its late-stage pipeline, AstraZeneca has pulled the plug on a phase 3 trial of its lung cancer treatment volrustomig.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.